ESC 365 - ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

ESC Premium Access

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Session: Hot Line Session 6

Topic: Anticoagulants

Speaker: Professor A. Goette (Paderborn, DE)

Event: ESC CONGRESS 2019

Congress Presentation

About the speaker

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)

33 presentations

0 follower

11 more presentations in this session

RAPID-TnT - A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Speaker: Professor D. Chew (Adelaide, AU)

Discussant review - RAPID-TnT

Speaker: Professor C. Mueller (Basel, CH)

Questions from the audience and discussion

Discussant review - ENTRUST-AF-PCI

Speaker: Professor R. Lopes (Durham, US)

Questions from the audience and discussion

Access the full session

Hot Line Session 6

Speakers: Professor A. Goette, Professor D. Chew, Professor C. Mueller, Professor R. Lopes

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

ESC Premium Access

Impacts of off-label dosing noacs on clinical outcomes in very elderly patients with atrial fibrillation

27 August 2021

ESC Premium Access

Net clinical benefit of direct oral anticoagulants in very elderly and high bleeding risk patients with atrial fibrillation who are often excluded from oral anticoagulation therapy: a nationwide popul

27 August 2021

ESC Premium Access

Low rate of worsening renal function after 2 years of treatment with edoxaban in patients from the ETNA-AF-Europe study

27 August 2021

ESC 365 is supported by